A detailed history of Northern Trust Corp transactions in Journey Medical Corp stock. As of the latest transaction made, Northern Trust Corp holds 92,742 shares of DERM stock, worth $736,371. This represents 0.0% of its overall portfolio holdings.

Number of Shares
92,742
Previous 84,992 9.12%
Holding current value
$736,371
Previous $610,000 7.54%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$6.9 - $8.54 $53,475 - $66,185
7,750 Added 9.12%
92,742 $656,000
Q2 2025

Aug 13, 2025

BUY
$5.97 - $8.07 $404,366 - $546,605
67,733 Added 392.45%
84,992 $610,000
Q4 2024

Feb 14, 2025

SELL
$3.97 - $6.53 $1,568 - $2,579
-395 Reduced 2.24%
17,259 $70,000
Q1 2024

May 14, 2024

BUY
$2.92 - $5.47 $2,920 - $5,470
1,000 Added 6.0%
17,654 $64,000
Q4 2023

Feb 13, 2024

BUY
$2.7 - $7.96 $44,965 - $132,565
16,654 New
16,654 $95,000

Others Institutions Holding DERM

About Journey Medical Corp


  • Ticker DERM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 11,596,500
  • Market Cap $92.1M
  • Description
  • Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...
More about DERM
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.